CellSeed Inc. (TYO:7776)
287.00
-8.00 (-2.71%)
At close: Feb 6, 2026
CellSeed Company Description
CellSeed Inc. engages in the cell sheet regenerative medicine business in Japan.
It is involved in the commercializing regenerative medicine using cell sheets. The company also offers cell cultureware services, and contract development and manufacturing services; UpCell, a temperature-responsive cell cultureware for cell sheet engineering; RepCell for cell collection; and HydroCell, a low cell binding cultureware.
In addition, it provides ThermoPlate III, a heating element; cellZscope, an automated cell monitoring systems; and cell sheet support products.
The company was incorporated in 2001 and is headquartered in Tokyo, Japan.
CellSeed Inc.
| Country | Japan |
| Founded | 2001 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 44 |
| CEO | Setsuko Hashimoto |
Contact Details
Address: Telecom Center Building Tokyo, 135-0064 Japan | |
| Phone | 81 3 6380 7490 |
| Website | cellseed.com |
Stock Details
| Ticker Symbol | 7776 |
| Exchange | Tokyo Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | JPY |
| ISIN Number | JP3423530009 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Setsuko Hashimoto | Chief Executive Officer |
| Jun Onodera | Chief Financial Officer |